MGS has started construction of its new innovation center at its headquarters campus in Germantown, Wisconsin.
The medtech contract manufacturer said the 120,000 ft² facility is scheduled to open by the end of 2024.
The MGS expansion will have collaborative workspaces dedicated to ideation and product development, tooling development, automation, and part and process validation, the plastics manufacturer said. Class 7 and 8 cleanrooms will offer space for part and process validation without disruption to production environments, while an on-site dedicated quality lab with enhanced tactile-, optical- and CT-measuring capabilities will ensure optical, dimensional and functional product quality throughout the product development process.
“The MGS Innovation Center represents an important milestone in our ongoing investment in supporting our growing customer base with end-to-end solutions from product development through delivery,” MGS CEO Paul Manley said in a news release.
MGS is consolidating its Germantown Global Automation Center and Menomonee Falls, Wisconsin Sampling Facility onto a single campus with the new Innovation Center.
“We look forward to bringing our early product development solutions together within our Wisconsin campus to help our customers bridge the gap between imagination and realization,” Manley said. “Together, we will uncover solutions to drive innovations that improve lives.”
MGS has 16 locations in the U.S. and Mexico, Ireland, Sweden, Denmark and Germany, including Healthcare Centers of Excellence in Germantown, Wisconsin and Leixlip, Ireland. Medtech applications for its products and services include diagnostics, drug delivery devices, fluid handling, nutrition and diabetes.